Palbociclib + Endocrine Therapy in Heavily Pretreated HR+/HER2− Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Breast
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Palbociclib Combined With Endocrine Therapy in Heavily Pretreated HR+/HER2− Advanced Breast Cancer Patients: Results From the Compassionate Use Program in Spain (PALBOCOMP)
Breast 2020 Nov 13;[EPub Ahead of Print], L Manso, C Hernando, M Galán, M Oliveira, MA Cabrera, R Bratos, CA Rodríguez, M Ruiz-Borrego, S Blanch, A Llombart-Cussac, JI Delgado-Mingorance, I Álvarez-Busto, I Gallegos, L González-Cortijo, S Morales, E Aguirre, BA Hernando, A Ballesteros, JE Alés-Martínez, C Reboredo, A Oltra, M González-Cao, M Santisteban, D Malón, I Echeverría, E García-Garre, E Vega, S Servitja, R Andrés, CE Robles, R López, E Galve, MJ Echarri, M Legeren, F MorenoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.